Refer A Patient

Request An Appointment

Other

ULTOMIRIS

ULTOMIRIS (ravulizumab-cwvz) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells.
Infusion or injection therapy referral
What it treats Paroxysmal Nocturnal Hemoglobinuria (PNH) in adults & Atypical Hemolytic Uremic Syndrome (aHUS) in adults and children one month of age or older
Prescribed by Hematologists or other prescribers specifically enrolled in the Ultomiris REMS program
How it’s administered Intravenous (IV) infusion
Frequency Every eight weeks, starting two weeks after an initial loading dose
Length of treatment Usually about two hours in adults & up to four hours in children

About This Therapy

ULTOMIRIS (ravulizumab-cwvz) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, helping to protect healthy cells from damage.

ULTOMIRIS is used to treat adults with a disease called Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare genetic disorder in which defective red blood cells break down prematurely and leak hemoglobin into the blood. ULTOMIRIS is also used to treat adults and children 1 month of age and older with a disease called atypical Hemolytic Uremic Syndrome (aHUS).

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

ULTOMIRIS REFERRAL FORM

ULTOMIRIS REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for ULTOMIRIS

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.